Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ittmann

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
The Prostate|August 24, 2006
Increased expression of the metastasis-associated gene Ehm2 in prostate cancerJianghua Wang, Yi Cai, Rebecca Penland, et al.
Croatian Medical Journal|November 5, 2020
Kallikrein gene family as biomarkers for recurrent prostate cancerFatma Busra Boyukozer, Esra Guzel Tanoglu, Mustafa Ozen, et al.
Cancer Biology & Therapy|December 17, 2005
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancerMoon S Koh, Michael Ittmann, Dov Kadmon, et al.
Cancer Research|October 17, 2008
Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcriptsJianghua Wang, Yi Cai, Wendong Yu, et al.
Cancer Letters|February 5, 2022
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomicsDallin Lowder, Kinza Rizwan, Collin McColl, et al.
The Prostate|July 30, 2003
In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptorTsang C Shao, Huiling Li, Wael Eid, et al.
Plos One|July 7, 2011
Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expressionLihong Yin, Pravin Rao, Paul Elson, et al.
The Prostate|October 23, 2018
MicroRNAs as prognostic markers in prostate cancerIlknur Suer, Esra Guzel, Omer F Karatas, et al.
The Prostate|May 22, 2019
Comparative analysis of p16 expression among African American and European American prostate cancer patientsMyra Wong, Yaeli Bierman, Curtis Pettaway, et al.
The Prostate|September 2, 2014
Differential expression of stem cell markers and ABCG2 in recurrent prostate cancerEsra Guzel, Omer F Karatas, Mehmet B Duz, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
The Prostate|August 24, 2006
Increased expression of the metastasis-associated gene Ehm2 in prostate cancerJianghua Wang, Yi Cai, Rebecca Penland, et al.
Croatian Medical Journal|November 5, 2020
Kallikrein gene family as biomarkers for recurrent prostate cancerFatma Busra Boyukozer, Esra Guzel Tanoglu, Mustafa Ozen, et al.
Cancer Biology & Therapy|December 17, 2005
CDC4 gene expression as potential biomarker for targeted therapy in prostate cancerMoon S Koh, Michael Ittmann, Dov Kadmon, et al.
Cancer Research|October 17, 2008
Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcriptsJianghua Wang, Yi Cai, Wendong Yu, et al.
Cancer Letters|February 5, 2022
Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomicsDallin Lowder, Kinza Rizwan, Collin McColl, et al.
The Prostate|July 30, 2003
In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptorTsang C Shao, Huiling Li, Wael Eid, et al.
Plos One|July 7, 2011
Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expressionLihong Yin, Pravin Rao, Paul Elson, et al.
The Prostate|October 23, 2018
MicroRNAs as prognostic markers in prostate cancerIlknur Suer, Esra Guzel, Omer F Karatas, et al.
The Prostate|May 22, 2019
Comparative analysis of p16 expression among African American and European American prostate cancer patientsMyra Wong, Yaeli Bierman, Curtis Pettaway, et al.
The Prostate|September 2, 2014
Differential expression of stem cell markers and ABCG2 in recurrent prostate cancerEsra Guzel, Omer F Karatas, Mehmet B Duz, et al.
Pageof 13